Research ArticleClinical Studies
L1CAM as a Negative Prognostic Factor in Endometrioid Endometrial Adenocarcinoma FIGO Stage IA-IB
JAROSLAV KLAT, ALES MLADENKA, JANA DVORACKOVA, SYLVA BAJSOVA and ONDREJ SIMETKA
Anticancer Research January 2019, 39 (1) 421-424; DOI: https://doi.org/10.21873/anticanres.13128
JAROSLAV KLAT
1Department of Obstetrics and Gynecology, University Hospital Ostrava, Ostrava Poruba, Czech Republic
ALES MLADENKA
1Department of Obstetrics and Gynecology, University Hospital Ostrava, Ostrava Poruba, Czech Republic
JANA DVORACKOVA
2Institute of Pathology, University Hospital Ostrava, Ostrava Poruba, Czech Republic
SYLVA BAJSOVA
1Department of Obstetrics and Gynecology, University Hospital Ostrava, Ostrava Poruba, Czech Republic
ONDREJ SIMETKA
1Department of Obstetrics and Gynecology, University Hospital Ostrava, Ostrava Poruba, Czech Republic
In this issue
Anticancer Research
Vol. 39, Issue 1
January 2019
L1CAM as a Negative Prognostic Factor in Endometrioid Endometrial Adenocarcinoma FIGO Stage IA-IB
JAROSLAV KLAT, ALES MLADENKA, JANA DVORACKOVA, SYLVA BAJSOVA, ONDREJ SIMETKA
Anticancer Research Jan 2019, 39 (1) 421-424; DOI: 10.21873/anticanres.13128
Jump to section
Related Articles
- No related articles found.
Cited By...
- Mesonephric-like Adenocarcinoma of the Uterine Corpus: Clinicopathological and Prognostic Significance of L1 Cell Adhesion Molecule (L1CAM) Over-expression
- L1CAM Is Not a Predictive Factor in Early-stage Squamous-cell Cervical Cancer
- L1 cell adhesion molecule (L1CAM) in stage IB cervical cancer: distinct expression in squamous cell carcinomas and adenocarcinomas
- Comprehensive bioinformatics analysis of L1CAM gene revealed Novel Pathological mutations associated with L1 syndrome